Gerald Sapp, University of Alabama at Birmingham transfusion service manager told Margaret Fritsma, MA SBB (ASCP)–who then told me–that Octapharma USA announced their human plasma-derived biological, Wilate® von Willebrand factor/coagulation factor VIII complex was cleared by the FDA 12/4/09. Click these links for Octapharma’s Wilate brochure and package insert.
Gerald wanted to know if anyone has experience with Wilate, and whether it is a valid substitute for Humate-P. I would also like to know if it can be monitored using the same methods, ristocetin cofactor (VWF:RCo) and factor VIII, as are used to monitor Humate-P. If you are using Wilate, please provide your information using the comments link. Thanks, Geo.